United Therapeutics Corporation (UTHR) has a consensus analyst rating of Buy, based on 30 analysts covering the stock. Of those, 16 recommend buying, 13 recommend holding, and 1 recommend selling.
The analyst consensus price target for UTHR is $579.83, representing a +0.2% upside from the current price of $578.54. Price targets range from a low of $447.00 to a high of $645.00.
